300 mg bd, increased by 300– 600 mg every 7 days; usual maintenance 600– 2400 mg daily, in divided doses. Plasma levels monitoring Plasma level monitoring of oxcarbazepine is not routinely warranted. Although correlations between dosage and plasma levels of oxcarbazepine, and between plasma lev...
ClinicalTrials数据库提供临床试验Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5 mL Under Fasting Conditions的登记号NCT00951600,试验分期N/A以及申办者Ranbaxy Laboratories Limited的信息,更过关于临床试验的其他信息查询就在戊戌数据美国临床试验数
(0.005 mg/kg, i.v.; Dai Han Pharm, Seoul, Korea) and sodium bicarbonate (1 mEq/kg, i.v.; Daewon Pham, Seoul, Korea) followed by mechanical chest compression (rate, 300/min) and mechanical ventilation with 100% oxygen until the electrocardiographic activity was shown and MAP reached 60...